At 11.40 am on the BSE, LTTS shares saw a 1.10 percent increase following the announcement of a collaboration with NVIDIA to introduce a Gen AI and advanced software-defined architecture for medical imaging in endoscopy. This joint development by LTTS and NVIDIA aims to create a scalable platform for the medical sector, offering features such as image processing pipeline, noise reduction, edge and contrast enhancement, and texture and color improvement.
Shanker Trivedi, Senior Vice President of Enterprise Business at NVIDIA, expressed that the collaboration offers value to the medical technology industry by expediting the development of AI-enabled, software-defined medical devices. The software-defined architecture is designed to enhance visualization for image processing and AI-based decision-making support, particularly in polyp detection and classification.
This collaboration between LTTS and NVIDIA is expected to bring significant benefits to the medical imaging industry by providing advanced tools for diagnosis and treatment planning. As a result of this partnership, we can expect more accurate diagnoses and better patient outcomes.